SHARE
Ankylosing Spondylitis - Global Market Outlook (2019 -2027)

Ankylosing Spondylitis - Global Market Outlook (2019 -2027)

4.2 (51 reviews)
Published: September 2020 ID: SMRC19958
4.2 (51 reviews)
Published: September 2020 ID: SMRC19958

1 Executive Summary       
         
2 Preface       
 
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Application Analysis     
 3.7 End User Analysis      
 3.8 Emerging Markets      
 3.9 Impact of Covid-19      
         
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes      
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Ankylosing Spondylitis Market, By Molecule Type   
 5.1 Introduction      
 5.2 Biologics       
 5.3 Biosimilars      
 5.4 Small Molecules      
         
6 Global Ankylosing Spondylitis Market, By Route of Administration  
 6.1 Introduction      
 6.2 Oral       
 6.3 Parenteral      
         
7 Global Ankylosing Spondylitis Market, By Dosage Form   
 7.1 Introduction      
 7.2 Liquid       
 7.3 Solid       
         
8 Global Ankylosing Spondylitis Market, By Drug    
 8.1 Introduction      
 8.2 Cimzia       
 8.3 Cosentyx       
 8.4 Enbrel       
 8.5 Humira       
 8.6 Remicade      
 8.7 Simponi       
         
9 Global Ankylosing Spondylitis Market, By Drug Type   
 9.1 Introduction      
 9.2 Anti-Inflammatory Drugs     
 9.3 COX Inhibitors      
 9.4 Disease-Modifying Anitrheumatic Drugs (DMARDs)   
 9.5 Immunosuppressive Drugs     
 9.6 JAK Inhibitors      
 9.7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)   
 9.8 Steroids       
 9.9 TNF Inhibitors      
 9.10 IL-17 Inhibitors      
         
10 Global Ankylosing Spondylitis Market, By Treatment Type   
 10.1 Introduction      
 10.2 Medication      
 10.3 Surgery       
 10.4 Therapy       
         
11 Global Ankylosing Spondylitis Market, By Application   
 11.1 Introduction      
 11.2 Adults       
 11.3 Juveniles       
         
12 Global Ankylosing Spondylitis Market, By End User    
 12.1 Introduction      
 12.2 Hospital       
 12.3 Care Home      
 12.4 Clinic       
         
13 Global Ankylosing Spondylitis Market, By Geography   
 13.1 Introduction      
 13.2 North America      
  13.2.1 US      
  13.2.2 Canada      
  13.2.3 Mexico      
 13.3 Europe       
  13.3.1 Germany      
  13.3.2 UK      
  13.3.3 Italy      
  13.3.4 France      
  13.3.5 Spain      
  13.3.6 Rest of Europe     
 13.4 Asia Pacific      
  13.4.1 Japan      
  13.4.2 China      
  13.4.3 India      
  13.4.4 Australia      
  13.4.5 New Zealand     
  13.4.6 South Korea     
  13.4.7 Rest of Asia Pacific     
 13.5 South America      
  13.5.1 Argentina     
  13.5.2 Brazil      
  13.5.3 Chile      
  13.5.4 Rest of South America    
 13.6 Middle East & Africa     
  13.6.1 Saudi Arabia     
  13.6.2 UAE      
  13.6.3 Qatar      
  13.6.4 South Africa     
  13.6.5 Rest of Middle East & Africa    
         
14 Key Developments       
 14.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 14.2 Acquisitions & Mergers     
 14.3 New Product Launch     
 14.4 Expansions      
 14.5 Other Key Strategies     
         
15 Company Profiling       
 15.1 Abbvie       
 15.2 Amgen       
 15.3 Boehringer Ingelheim     
 15.4 Bristol-Myers Squibb     
 15.5 Celgene       
 15.6 Celltrion       
 15.7 Eisai       
 15.8 Eli Lilly and Company     
 15.9 F. Hoffmann-La Roche     
 15.10 Janssen Pharmaceuticals     
 15.11 Johnson & Johnson Services, Inc    
 15.12 Merck & Co      
 15.13 Novartis AG      
 15.14 Pfizer       
 15.15 Regeneron Pharmaceuticals     
 15.16 Sanofi       
 15.17 Shanghai Pharmaceuticals     
 15.18 UCB, Inc      


List of Tables        
1 Global Ankylosing Spondylitis Market Outlook, By Region (2018-2027) ($MN) 
2 Global Ankylosing Spondylitis Market Outlook, By Molecule Type (2018-2027) ($MN)
3 Global Ankylosing Spondylitis Market Outlook, By Biologics (2018-2027) ($MN) 
4 Global Ankylosing Spondylitis Market Outlook, By Biosimilars (2018-2027) ($MN) 
5 Global Ankylosing Spondylitis Market Outlook, By Small Molecules (2018-2027) ($MN)
6 Global Ankylosing Spondylitis Market Outlook, By Route of Administration (2018-2027) ($MN)
7 Global Ankylosing Spondylitis Market Outlook, By Oral (2018-2027) ($MN) 
8 Global Ankylosing Spondylitis Market Outlook, By Parenteral (2018-2027) ($MN) 
9 Global Ankylosing Spondylitis Market Outlook, By Dosage Form (2018-2027) ($MN) 
10 Global Ankylosing Spondylitis Market Outlook, By Liquid (2018-2027) ($MN) 
11 Global Ankylosing Spondylitis Market Outlook, By Solid (2018-2027) ($MN) 
12 Global Ankylosing Spondylitis Market Outlook, By Drug (2018-2027) ($MN) 
13 Global Ankylosing Spondylitis Market Outlook, By Cimzia (2018-2027) ($MN) 
14 Global Ankylosing Spondylitis Market Outlook, By Cosentyx (2018-2027) ($MN) 
15 Global Ankylosing Spondylitis Market Outlook, By Enbrel (2018-2027) ($MN) 
16 Global Ankylosing Spondylitis Market Outlook, By Humira (2018-2027) ($MN) 
17 Global Ankylosing Spondylitis Market Outlook, By Remicade (2018-2027) ($MN) 
18 Global Ankylosing Spondylitis Market Outlook, By Simponi (2018-2027) ($MN) 
19 Global Ankylosing Spondylitis Market Outlook, By Drug Type (2018-2027) ($MN) 
20 Global Ankylosing Spondylitis Market Outlook, By Anti-Inflammatory Drugs (2018-2027) ($MN)
21 Global Ankylosing Spondylitis Market Outlook, By COX Inhibitors (2018-2027) ($MN)
22 Global Ankylosing Spondylitis Market Outlook, By Disease-Modifying Anitrheumatic Drugs (DMARDs) (2018-2027) ($MN)
23 Global Ankylosing Spondylitis Market Outlook, By Immunosuppressive Drugs (2018-2027) ($MN)
24 Global Ankylosing Spondylitis Market Outlook, By JAK Inhibitors (2018-2027) ($MN)
25 Global Ankylosing Spondylitis Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2018-2027) ($MN)
26 Global Ankylosing Spondylitis Market Outlook, By Steroids (2018-2027) ($MN) 
27 Global Ankylosing Spondylitis Market Outlook, By TNF Inhibitors (2018-2027) ($MN)
28 Global Ankylosing Spondylitis Market Outlook, By IL-17 Inhibitors (2018-2027) ($MN)
29 Global Ankylosing Spondylitis Market Outlook, By Treatment Type (2018-2027) ($MN)
30 Global Ankylosing Spondylitis Market Outlook, By Medication (2018-2027) ($MN) 
31 Global Ankylosing Spondylitis Market Outlook, By Surgery (2018-2027) ($MN) 
32 Global Ankylosing Spondylitis Market Outlook, By Therapy (2018-2027) ($MN) 
33 Global Ankylosing Spondylitis Market Outlook, By Application (2018-2027) ($MN) 
34 Global Ankylosing Spondylitis Market Outlook, By Adults (2018-2027) ($MN) 
35 Global Ankylosing Spondylitis Market Outlook, By Juveniles (2018-2027) ($MN) 
36 Global Ankylosing Spondylitis Market Outlook, By End User (2018-2027) ($MN) 
37 Global Ankylosing Spondylitis Market Outlook, By Hospital (2018-2027) ($MN) 
38 Global Ankylosing Spondylitis Market Outlook, By Care Home (2018-2027) ($MN) 
39 Global Ankylosing Spondylitis Market Outlook, By Clinic (2018-2027) ($MN) 
         
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Select License Type

Single User License (PDF)
2 - 5 User License (PDF)
Site License (PDF)
Corporate License (PDF)

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials